Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes

US Patent 8440668 · Granted May 14, 2013

Estimated economic value: $107,206,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Display device and method of driving display device2025
Fused pentacyclic imidazole derivatives2024
AMPK activators2023
Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as C2023
Antimalarial hexahydropyrimidine analogues2022
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists2021
Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors2021
Aminopyrimidine compound2021
Alkoxy bis-heteroaryl derivatives as modulators of protein aggregation2021
Fused pentacyclic imidazole derivatives as modulators of TNF activity2021
Bis-heteroaryl derivatives as modulators of protein aggregation2021
Bicyclic bis-heteroaryl derivatives as modulators of protein aggregation2021